Back to Results
First PageMeta Content
Morphinans / Euphoriants / Alcohols / Ketones / Opiates / Oxycodone / Purdue Pharma / Doctor shopping / Percodan / Chemistry / Medicine / Organic chemistry


FACT SHEET OxyContin
Add to Reading List

Document Date: 2012-04-05 12:31:32


Open Document

File Size: 82,80 KB

Share Result on Facebook

City

Winnipeg / Ottawa / Washington / D.C. / Toronto / /

Company

Purdue Pharma / /

Country

United States / Canada / /

Currency

USD / /

/

Event

Product Recall / Product Issues / /

/

IndustryTerm

pharmaceutical industry / intelligence tools / law enforcement / opioid analgesic products / chemicals / /

MedicalCondition

Loss of consciousness / chronic pain / chronic non-malignant pain / chronic noncancer pain / cancer / adolescent drug abuse / pain / drug abuse / withdrawal symptoms / /

MedicalTreatment

cognitive-behavioural therapies / counselling / /

Organization

U.S. Department of Health and Human Services / Centre for Addiction and Mental Health / National Institute on Drug Abuse / Government of Newfoundland and Labrador / Task Force / In Canadian Centre on Substance Abuse / U.S. Department of Justice / FDA / Canadian Centre on Substance Abuse / Canadian Centre on Substance Abuse Sources Adlaf / Addictions Foundation of Manitoba / Drug Enforcement Administration / Mental Health / /

Person

John Weekes / /

/

Position

physician / Senior Research Analyst / Governor / Kicker / /

Product

symptoms / Oxycodone Hydrochloride / Percocet / Percodan / OxyContin / /

ProvinceOrState

Virginia / Newfoundland / Manitoba / Ontario / /

Technology

alpha / /

URL

www.DEAdiversion.usdoj.gov / www.purdue.ca / www.ccsa.ca / www.ccsa.ca—follow / /

SocialTag